BENEFIT 11

• Research type

  Research Study

• Full title

  BENEFIT 11 a long-term, follow-up study (16401) of the BENEFIT (304747), BENEFIT Follow-up (305207) Studies and BENEFIT Extension (311129) Study to further evaluate the progress of patients with first demyelinating event suggestive of multiple sclerosis

• IRAS ID

  124937

• Contact name

  Richard Coleman

• Sponsor organisation

  Bayer HealthCare AG

• Eudract number

  2012-005262-35

• REC name

  Scotland A REC

• REC reference

  13/SS/0110

• Date of REC Opinion

  14 Aug 2013

• REC opinion

  Further Information Favourable Opinion